News

Tirzepatide improves outcomes in patients with obesity-related HFpEF regardless of the severity of their baseline BMI or fat ...
Costa Rica: A recent systematic review published in the Cureus Journal of Medical Science has shed light on the potential of ...
Tirzepatide outperformed semaglutide in simultaneously achieving four key therapeutic targets for type 2 diabetes.
Hormone therapy as an adjunctive to tirzepatide was associated with greater weight loss than tirzepatide alone among postmenopausal women.
Patients regain weight after stopping weight loss drugs, long-term success may depend on lifestyle and drug choice.
It isn't easy finding high-yield dividend growth stocks when the market is at an all-time high. Shares of Novo Nordisk and ...
Willingness to try new drugs for obesity management have propelled the growth of this market, which today is almost five ...
Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...
Morrisons has launched its own £129-a month fat jab club leaving many shoppers unimpressed as they criticised it for selling ...
A new report from The Center for Medicine in the Public Interest (CMPI) warns that regulators are failing to stop the illegal ...
Key TakeawaysThe weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer. Tumor ...
Patients put on weight loss drugs like Ozempic and Wegovy may start regaining weight within weeks of discontinuing them, a ...